icad inc. (ICAD) News
Filter ICAD News Items
ICAD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ICAD News Highlights
- ICAD's 30 day story count now stands at 2.
- Over the past 13 days, the trend for ICAD's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about ICAD are DEC and HUGE.
Latest ICAD News From Around the Web
Below are the latest news stories about ICAD INC that investors may wish to consider to help them evaluate ICAD as an investment opportunity.
iCAD Expands Executive Sales Leadership Team as Business GrowsBill Keyes shifts and expands his role to Senior Vice President, Global Sales Operations and Peter Graham joins iCAD as Senior Vice President, North American Sales to accelerate growth while organization adds new products and partnerships.NASHUA, N.H., Dec. 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice Presi |
Wealth Accumulation: 3 Stocks with Multibagger PotentialWhile it’s never easy to identify multibagger stocks, this may be one of the best times in decades to “swing for the fences” by buying undervalued growth names that are well-positioned to at least triple over the next few years. Amid excessive worries about interest rates, the Street has pushed down many unprofitable, high-potential companies’ stocks to absurdly low levels. Now that those fears are dissipating, these firms are well-positioned to make huge comebacks. Interest rates recently dropp |
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE HealthcareKey apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite*AI applications streamline workflow and support clinicians in delivering more personalized breast care, including cancer detection, density assessment, and recommendations NASHUA, N.H., Nov. 28, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions |
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart DiseaseNew research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast canceriCAD unveils new solution that assesses calcium deposits in the breast arteries as a proxy for hidden cardiovascular disease, the leading cause of death for women in the U.S.Dr. Emily Conant, Perelman School of Medicine, University of Pennsylvania, to present how iCAD’s 4th generation Breast AI is harnessing inn |
Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive ReturnsAs the Street realizes that we're in the early stages of the business cycle, penny stocks should boom. |
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care SolutionOffering radiology the most complete breast health solution, including breast density assessment, breast cancer detection, and thorough risk evaluation, including lifetime, genetic, and short-term 1- or 2-year AI-riskPartnership to expand access to ProFound Breast Health Suite and CancerIQ’s platform to benefit patients across thousands of facilities NASHUA, N.H. and CHICAGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-dete |
This iCAD Insider Increased Their Holding In The Last YearInsiders were net buyers of iCAD, Inc.'s ( NASDAQ:ICAD ) stock during the past year. That is, insiders bought more... |
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select ConferenceNASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that Dana Brown, President and Chief Executive Officer and Eric Lonnqvist, Chief Financial Officer, will participate at the 14th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16th. The conference will be held at the Sheraton New York Times Square in Ne |
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023Company to host conference call and webcast today at 4:30 PM ETNASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months ended September 30, 2023. Highlights: Completed sale of Xoft, its therapy business line, to Elekta thereby enabling the Company to focus exclusi |
7 Biotech Stocks to Buy for Big-Time GainsBiotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research. |